Harvard Bioscience (HBIO) EBT Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported EBT Margin of 15.93% for Q1 2026, up 21734.0% year-over-year from N/an in Q1 2025, and down 18.03% on a QoQ basis from 13.5% in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of EBT Margin data on file, last reported at 15.93% in Q1 2026.
- Quarterly EBT Margin rose 21734.0% year-over-year to 15.93% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.57% (up 5186.0% YoY) and the FY2025 annual result came in at 66.3%, down 5391.0% from the prior year.
- EBT Margin retreated to 15.93% in Q1 2026 per HBIO's latest filing, from 13.5% in the prior quarter.
- Across five years, EBT Margin topped out at 11.71% in Q2 2022 and bottomed at 233.28% in Q1 2025.
- The 5-year median for EBT Margin is 11.02% (2025), against an average of 21.91%.
- The widest annual swing landed in 2025, when EBT Margin slumped 21499 bps; it then surged 21734 bps in 2026.
- Tracing HBIO's EBT Margin over 5 years: stood at 3.14% in 2022, then decreased by 25 bps to 3.92% in 2023, then soared by 161 bps to 2.4% in 2024, then sank by 662 bps to 13.5% in 2025, then slipped by 18 bps to 15.93% in 2026.
- Per Business Quant, the three latest HBIO EBT Margin figures stand at 15.93% (Q1 2026), 13.5% (Q4 2025), and 5.51% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 33.94% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 0.83% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 35.09% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 21.32% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.80% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 18.77% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 14.31% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -0.22% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 9.54% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -15.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.93% |
| Dec 31, 2025 | -13.50% |
| Sep 30, 2025 | -5.51% |
| Jun 30, 2025 | -11.02% |
| Mar 31, 2025 | -233.28% |
| Dec 31, 2024 | 2.40% |
| Sep 30, 2024 | -20.44% |
| Jun 30, 2024 | -14.20% |
| Mar 31, 2024 | -18.29% |
| Dec 31, 2023 | -3.92% |
| Sep 30, 2023 | -2.22% |
| Jun 30, 2023 | -7.30% |
| Mar 31, 2023 | 4.03% |
| Dec 31, 2022 | -3.14% |
| Sep 30, 2022 | -17.42% |
| Jun 30, 2022 | 11.71% |
| Mar 31, 2022 | -24.39% |
| Dec 31, 2021 | 3.42% |
| Sep 30, 2021 | 0.15% |
| Jun 30, 2021 | -2.16% |
| Mar 31, 2021 | -2.53% |
| Dec 31, 2020 | -1.77% |
| Sep 30, 2020 | -5.89% |
| Jun 30, 2020 | -3.72% |
| Mar 31, 2020 | -18.77% |
| Dec 31, 2019 | 0.32% |
| Sep 30, 2019 | -9.75% |
| Jun 30, 2019 | -3.83% |
| Mar 31, 2019 | -6.36% |
| Dec 31, 2018 | 0.13% |
| Sep 30, 2018 | -3.17% |
| Jun 30, 2018 | -5.92% |
| Mar 31, 2018 | -19.60% |
| Dec 31, 2017 | -2.19% |
| Sep 30, 2017 | -3.55% |
| Jun 30, 2017 | -3.86% |
| Mar 31, 2017 | -4.15% |
| Dec 31, 2016 | -3.74% |
| Sep 30, 2016 | -3.52% |
| Jun 30, 2016 | -2.93% |
| Mar 31, 2016 | -1.64% |
| Dec 31, 2015 | -1.13% |
| Sep 30, 2015 | -4.26% |
| Jun 30, 2015 | -1.48% |
| Mar 31, 2015 | -6.85% |
| Dec 31, 2014 | 3.86% |
| Sep 30, 2014 | 3.76% |
| Jun 30, 2014 | 4.71% |
| Mar 31, 2014 | 3.94% |
| Dec 31, 2013 | -4.55% |
| Sep 30, 2013 | 0.22% |
| Jun 30, 2013 | 1.59% |
| Mar 31, 2013 | 4.72% |
| Dec 31, 2012 | 7.04% |
| Sep 30, 2012 | 3.75% |
| Jun 30, 2012 | 7.89% |
| Mar 31, 2012 | 5.92% |
| Dec 31, 2011 | 3.39% |
| Sep 30, 2011 | -0.45% |
| Jun 30, 2011 | 7.37% |
| Mar 31, 2011 | 6.37% |
| Dec 31, 2010 | -14.10% |
| Sep 30, 2010 | 5.91% |
| Jun 30, 2010 | 9.64% |